46 related articles for article (PubMed ID: 25750333)
1. Cyclin A correlates with YB1, progression and resistance to chemotherapy in human epithelial ovarian cancer.
Cybulski M; Jarosz B; Nowakowski A; Jeleniewicz W; Kutarska E; Bednarek W; Stepulak A
Anticancer Res; 2015 Mar; 35(3):1715-21. PubMed ID: 25750333
[TBL] [Abstract][Full Text] [Related]
2. Role of Serine arginine protein kinase 1 and Minichromosome maintenance protein 2 in predicting epithelial ovarian cancer response to treatment and prognosis.
Elkholy E; Abdou AG; Alhanafy AM; Hashem T; Hassan R; Shehata M
Indian J Cancer; 2024 Jan; ():. PubMed ID: 38216547
[TBL] [Abstract][Full Text] [Related]
3. YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.
Somasekharan SP; El-Naggar A; Leprivier G; Cheng H; Hajee S; Grunewald TG; Zhang F; Ng T; Delattre O; Evdokimova V; Wang Y; Gleave M; Sorensen PH
J Cell Biol; 2015 Mar; 208(7):913-29. PubMed ID: 25800057
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
[TBL] [Abstract][Full Text] [Related]
5. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.
Sheridan CM; Grogan TR; Nguyen HG; Galet C; Rettig MB; Hsieh AC; Ruggero D
Oncotarget; 2015 Apr; 6(10):7470-80. PubMed ID: 25797255
[TBL] [Abstract][Full Text] [Related]
6. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway.
Liu M; Chen J; Huang Y; Ke J; Li L; Huang D; Wu W
Pharmazie; 2015 Apr; 70(4):244-50. PubMed ID: 26012254
[TBL] [Abstract][Full Text] [Related]
7. YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment.
Gopal SK; Greening DW; Mathias RA; Ji H; Rai A; Chen M; Zhu HJ; Simpson RJ
Oncotarget; 2015 May; 6(15):13718-30. PubMed ID: 25980435
[TBL] [Abstract][Full Text] [Related]
8. Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer.
Fukuda T; Imai K; Yamauchi M; Teramae M; Hashiguchi Y; Ichimura T; Yasui T; Sumi T
Eur J Gynaecol Oncol; 2015; 36(1):49-53. PubMed ID: 25872334
[TBL] [Abstract][Full Text] [Related]
9. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
10. The expression level and prognostic value of Y-box binding protein-1 in rectal cancer.
Zhang Y; Zhao PW; Feng G; Xie G; Wang AQ; Yang YH; Wang D; Du XB
PLoS One; 2015; 10(3):e0119385. PubMed ID: 25790262
[TBL] [Abstract][Full Text] [Related]
11. Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis.
Zhu GQ; Shi KQ; Huang S; Huang GQ; Lin YQ; Zhou ZR; Braddock M; Chen YP; Zheng MH
Medicine (Baltimore); 2015 Mar; 94(11):e609. PubMed ID: 25789951
[TBL] [Abstract][Full Text] [Related]
12. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494.
Han X; Fang Z; Wang H; Jiao R; Zhou J; Fang N
Biochem Biophys Res Commun; 2016 Nov; 480(4):675-681. PubMed ID: 27983981
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.
Huang KC; Yang J; Ng MC; Ng SK; Welch WR; Muto MG; Berkowitz RS; Ng SW
Eur J Cancer; 2016 Nov; 67():152-163. PubMed ID: 27669502
[TBL] [Abstract][Full Text] [Related]
14. Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.
Zhang Y; Tao L; Fan LX; Huang K; Luo HM; Ge H; Wang X; Wang Q
Mol Med Rep; 2019 Mar; 19(3):2287-2296. PubMed ID: 30664215
[TBL] [Abstract][Full Text] [Related]
15. CTD-2020K17.1, a Novel Long Non-Coding RNA, Promotes Migration, Invasion, and Proliferation of Serous Ovarian Cancer Cells In Vitro.
Zhu L; Guo Q; Lu X; Zhao J; Shi J; Wang Z; Zhou X
Med Sci Monit; 2018 Mar; 24():1329-1339. PubMed ID: 29504606
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract][Full Text] [Related]
17. Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer.
Tang XH; Deng S; Li M; Lu MS
Tumour Biol; 2016 Apr; 37(4):5521-8. PubMed ID: 26572150
[TBL] [Abstract][Full Text] [Related]
18. The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Rossini E; Tamburello M; Abate A; Zini S; Ribaudo G; Gianoncelli A; Calza S; Valcamonico F; Suardi NR; Mirabella G; Berruti A; Sigala S
Cells; 2024 Feb; 13(5):. PubMed ID: 38474332
[TBL] [Abstract][Full Text] [Related]
19. Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer.
Howard D; James D; Garcia-Parra J; Pan-Castillo B; Worthington J; Williams N; Coombes Z; Rees SC; Lutchman-Singh K; Francis LW; Rees P; Margarit L; Conlan RS; Gonzalez D
Front Oncol; 2022; 12():1014280. PubMed ID: 36505806
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro.
Tsaur I; Thomas A; Taskiran E; Rutz J; Chun FK; Haferkamp A; Juengel E; Blaheta RA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
